Initial clinical experience with the novel POLARx FIT cryoballoon system for pulmonary vein isolation in patients with atrial fibrillation
IJC Heart & Vasculature · 2024-02 · 50 · 101326
DOI: 10.1016/j.ijcha.2023.101326 ↗Kurz gefasst
Fachartikel in der Zeitschrift IJC Heart & Vasculature, 2024-02. Verfasst von Hiroshi Fukunaga und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Sakakibara Heart Institute, 3-16-1 Asahi-cho, Tokyo 183-0003, Japan. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The POLARx FIT system (Boston Scientific, MA, USA) is a novel cryoballoon (CB) ablation technology in which the balloon diameter can be expanded from 28 to 31 mm. The aim of this study was to compare the benefits and safety of the new POLARx FIT system to those of the existing POLARx system currently in use for pulmonary vein (PV) isolation (PVI) in patients with atrial fibrillation.
Methods
The first 70 consecutive patients who underwent CB-based PVI with the POLARx FIT system were retrospectively compared with 200 consecutive patients treated with the POLARx system at Sakakibara Heart Institute from October 2021 to May 2023.
Results
The POLARx FIT system yielded a higher mean ± standard deviation nadir temperature in the right inferior PV (-59.2 ± 5.29 °C vs. - 62.0 ± 5.08 °C, p = 0.006), but this required a balloon size reduction to 28 mm in 30 % of cases. No significant differences were detected in the time to isolation and thaw time of any PV between the two groups. After the CB-based PVI procedure, no residual PV carina potentials were observed with the POLARx FIT system, whereas 4/20 were with the POLARx system (p = 0.04).
Conclusions
The POLARx FIT system had comparable effectiveness and safety to the basic POLARx system. This technology may improve the ablation area, including the PV carina. However, the 31-mm balloon alone was not sufficient to isolate certain PVs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Sakakibara Heart Institute, 3-16-1 Asahi-cho, Tokyo 183-0003, Japan.
Zitieren
APA
Fukunaga, H., Sekiguchi, Y., Sawaguchi, J., Hayashi, Y., Asano, S., Mabuchi, K., Inoue, K., Tanizaki, K., Umemura, J., Isobe, M., & Nitta, J. (2024). Initial clinical experience with the novel POLARx FIT cryoballoon system for pulmonary vein isolation in patients with atrial fibrillation. IJC Heart & Vasculature, 50, 101326. https://doi.org/10.1016/j.ijcha.2023.101326
Vancouver
Fukunaga H, Sekiguchi Y, Sawaguchi J, Hayashi Y, Asano S, Mabuchi K, et al. Initial clinical experience with the novel POLARx FIT cryoballoon system for pulmonary vein isolation in patients with atrial fibrillation. IJC Heart & Vasculature. 2024;50:101326. doi:10.1016/j.ijcha.2023.101326
BibTeX
@article{Fukunaga2024,
author = {Fukunaga, Hiroshi and Sekiguchi, Yukio and Sawaguchi, Jun and Hayashi, Yosuke and Asano, Sou and Mabuchi, Kei and Inoue, Kanki and Tanizaki, Kohei and Umemura, Jun and Isobe, Mitsuaki and Nitta, Junichi},
title = {Initial clinical experience with the novel POLARx FIT cryoballoon system for pulmonary vein isolation in patients with atrial fibrillation},
journal = {IJC Heart & Vasculature},
year = {2024},
volume = {50},
pages = {101326},
doi = {10.1016/j.ijcha.2023.101326}
}
EUVIMED